Pan‐cancer analysis of RPL36A expression revealed significant differences across various tumour types, including hepatocellular carcinoma, breast cancer, colon cancer and NSCLC, compared to normal tissues (Figure 7D). Here, RPL36A is linked to malignant colon neoplasm.